Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off ...

Howard Marks dissects market madness, separating price from value, and warns investors: fundamentals are fading while ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.65, with a ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.56, along ...

Trump's flip-flopping on Intel highlights the impact of politics on investor sentiment. New leadership, government investment ...

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

Wyoming has become the first U.S. public entity to issue a blockchain-based stablecoin, launching the Frontier Stable Token ...

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when ...

The Social Security Administration recently announced the addition of 13 conditions to its Compassionate Allowances list, a ...

Nvidia's China woes have major implications for tech ETFs as Beijing pressures firms to use domestic alternatives. Near-term ...

Needham analyst initiates AeroVironment at Buy with a $300 target, citing drone market growth, BlueHalo deal and rising ...

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...